Publicaciones en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (101)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)

    Ophthalmology and Therapy

  5. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  6. Impact of fragility fractures in postmenopausal Spanish women with osteoporosis

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 15, Núm. 4, pp. 135-143

  7. POS0652 Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: Uvedai

    Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 604-605

  8. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  9. Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  10. Prognostic utility of pulse pressure in patients with heart failure with preserved ejection fraction: RICA Registry

    Revista Clinica Espanola, Vol. 223, Núm. 4, pp. 231-239

  11. Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice

    Future cardiology, Vol. 19, Núm. 6, pp. 343-351

  12. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease

    Nefrologia

  13. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease

    Nefrologia

  14. SER recommendations for the treatment of uveitis

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477

  15. Shared decision-making quality and decisional regret in patients with low-risk superficial basal cell carcinoma: A prospective, multicenter cohort study

    JAAD International, Vol. 13, pp. 159-163

  16. Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis

    Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055